Biotec Pharmacon ASA | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
48.33 M |
Public Float |
- |
Biotec Pharmacon ASA | |
Stock Exchange | Oslo Stock Exchange |
EPS |
NOK0.26 |
Market Cap |
NOK200.59 M |
Shares Outstanding |
48.33 M |
Public Float |
47.88 M |
Address |
Siva Innovasjonssenter Tromsø TR 9019 Norway |
Employees | - |
Website | http://www.biotec.no |
Updated | 07/08/2019 |
Biotec Pharmacon ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Beta-Glucans segments. The Enzymes segment consists of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing. |